Serum enterolactone and postmenopausal breast cancer risk by estrogen, progesterone and herceptin 2 receptor status.Published in:International Journal of Cancer, 2012, v. 130, n. 6, p. 1401, doi. 10.1002/ijc.26157By:Zaineddin, Aida Karina;Vrieling, Alina;Buck, Katharina;Becker, Susen;Linseisen, Jakob;Flesch-Janys, Dieter;Kaaks, Rudolf;Chang-Claude, JennyPublication type:Article